New studies advance the mechanistic understanding of mutant histone H3 in diffuse intrinsic pontine glioma (DIPG) and demonstrate two epigenetic approaches, BET inhibition and EZH2 inhibition, as potential therapeutic strategies for DIPG.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Buczkowicz, P. & Hawkins, C. Front. Oncol. 5, 147 (2015).
Schwartzentruber, J. et al. Nature 482, 226–231 (2012).
Buczkowicz, P. et al. Nat. Genet. 46, 451–456 (2014).
Wu, G. et al. Nat. Genet. 46, 444–450 (2014).
Mohammad, F. et al. Nat. Med. 23, 483–492 (2017).
Piunti, A. et al. Nat. Med. 23, 493–500 (2017).
Kallappagoudar, S., Yadav, R.K., Lowe, B.R. & Partridge, J.F. Chromosoma 124, 177–189 (2015).
Lewis, P.W. et al. Science 340, 857–861 (2013).
Bender, S. et al. Cancer Cell 24, 660–672 (2013).
Chan, K.M. et al. Genes Dev. 27, 985–990 (2013).
Schroeder, K.M., Hoeman, C.M. & Becher, O.J. Pediatr. Res. 75, 205–209 (2013).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
C.L.C. is an employee and stock owner of GSK, a company with compounds in clinical development for both EZH2 and BET. The two articles that are summarized in the News & Views article indicate that treatment with inhibitors of EZH2 or BET may be an effective therapy for diffuse intrinsic pontine glioma.
Rights and permissions
About this article
Cite this article
Creasy, C. Untangling the role of mutant histone H3 in diffuse intrinsic pontine glioma. Nat Med 23, 413–414 (2017). https://doi.org/10.1038/nm.4320
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.4320